CAFs secrete epidermal growth factor (EGF) that upregulates integrin α5 (ITGA5) expression on tumor cells, as well as TGF-β1, leading to strengthened tumor–stromal interactions inside malignant units. This evidence concerns the gene ITGA5 and neoplasm.